Fig. 1. Example of proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia in a patient pre-dating the original description in 2007. The patient,

Slides:

Advertisements

Similar presentations

Proton Pump Inhibitors

Advertisements

KAVITHA KANAKANTI.  To confirm the number of patients who were on Clopidogrel are taking Proton Pump Inhibitors.

David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

DYSPEPSIA Dr.Vishal Rathore. Dyspepsia popularly known as indigestion meaning hard or difficult digestion, is a medical condition characterized by chronic.

In patients with Gastroesophageal Reflux Disease is Esomeprazole the most efficient proton pump inhibitor to induce mucosal healing? Introdução à Medicina.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

National Therapeutic Indicators – How can EMIS help? Dr Keith Burns, EMIS NUG Committee, Broadbay Medical Practice, Stornoway.

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:

RA. F.A. is a 25-year-old woman with RA. On diagnosis 1 year ago, F.A. had an RF titer of 1:64, signs and symptoms of inflammation in the joints of both.

3:00. 2:59 2:58 2:57 2:56 2:55 2:54 2:53 2:52.

By: Ashley Whiteaker.  Peptic ulcers are ulcers that form in the stomach or the upper part of the small intestine, called the duodenum. It is an sore.

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy of Omeprazole for the Treatment of Symptomatic.

Treatment for Upper GI bleeding due to PUD. Goals Control upper GI bleeding Provide symptom relief Promote ulcer healing Prevent recurrence and other.

The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.

JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.

Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: GERD-Related Chronic Laryngitis: Pro Arch Otolaryngol.

PROTON PUMP INHIBITORS (PPI)

Lip augmentation Dr Per Hedén.

S4 Fig. REMARK diagram of course selection for analysis of ctDNA pre-treatment and for ctDNA change after the first and second cycle of chemotherapy. Courses.

Drugs for Gastrointestinal and Related Diseases

Copyright © 2011 American Medical Association. All rights reserved.

HRB Centre for Primary Care Research, RCSI, Dublin

Fig. 9. Hemorrhagic hyperdense fluid in colon in 50-year-old deceased woman (case 11). CT scan obtained 2 hours and 17 minutes after death shows hyperdense.

Fig. 2.The intestinal secretory IgA (sIgA) antibody response was measured in chickens against the outer membrane protein for 7 weeks PPI. Antibody levels.

Fig. 5. Levels of apoptosis-associated proteins following treatment with parthenolide (PT) and balsalazide. HCT116 cell lysates were prepared after treatment.

Abbreviations: GERD, gastroesophageal reflux disease; H2RA, histamine2-receptor agonist; PA, prokinetic agent; PPI, proton-pump inhibitor. Source: Economic.

Copyright © 2011 American Medical Association. All rights reserved.

From: The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors Invest. Ophthalmol.

THE APPROPRIATENESS OF PPI PRESCRIPTION IN A GENERAL MEDICAL COHORT

Treatment List: Case # { } {List treatment and tooth numbers}

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Top Fire Protection Services Ottawa available on Dubinskyconstruction

Figure 4 Activation of clopidogrel via cytochrome P450

Safety of Proton Pump Inhibitor Exposure

Jeffrey F. Barletta, PharmD, Shareen Y. El-Ibiary, PharmD, Lindsay E

Acute kidney injury following proton pump inhibitor therapy

The “dangers” of chronic proton pump inhibitor use

Pharmacoeconomics of Coxib Therapy

Volume 4, Issue 3, Pages (April 2018)

Bushinsky et al. Am J Nephrol 2016;44: (DOI: / )

Figure 2 Effect of PPIs on gastric physiology

داروهای کاهنده حرکت و ترشح

Intragastric pH With Oral vs Intravenous Bolus Plus Infusion Proton-Pump Inhibitor Therapy in Patients With Bleeding Ulcers Loren Laine, Abbid Shah,

A) CT scan of patient number 1, before pembrolizumab; b) CT scan of patient number 1, after 11 pembrolizumab infusions; c) CT scan of patient number 1,

Management of Patients With Functional Heartburn

Proton pump inhibitors use and risk of chronic kidney disease: Evidence-based meta- analysis of observational studies Salman Hussain, Ambrish Singh, Anwar.

Ikuo Hirano, Qing Zhang, John E. Pandolfino, Peter J. Kahrilas

What number is the arrow pointing at?

Patrick Hoversten, Fouad Otaki, David A. Katzka

Figure 5 PPIs and adverse events with proven and unproven causality

Example 1 Written Description:

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009 Yolanda P. Lillquist,

Efficacy of intravenous magnesium in neuropathic pain

Volume 154, Issue 4, Pages (March 2018)

Effects of magnesium sulphate on intraoperative anaesthetic requirements and postoperative analgesia in gynaecology patients receiving total intravenous.

Kensuke Nishimiya et al. JCIN 2016;9:

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Jai Moo Shin, George Sachs Gastroenterology

Thing / Person:____________________ Dates:_________________

Forest plots of randomised controlled trials and propensity score matched studies examining outcomes between patients taking proton pump inhibitor (PPIs)

Raw EEG characteristics, bispectral index, and suppression ratio variations during generalized seizure in electroconvulsive therapy A Ntahe, G Fournis,

Fig. 6. Mucus analysis of lungs from allergic and tolerized mice

Forest plot of studies examining outcomes between patients taking proton pump inhibitor (PPIs) with clopidogrel and those taking only clopidogrel: (A)

Fig. 5 In vivo evaluation of F-insulin for treatment of type 1 diabetic minipig. In vivo evaluation of F-insulin for treatment of type 1 diabetic minipig.

Fig. 2. One case of recurrence out of 12 adult patients with totally resected ependymomas without anaplastic pathology or postoperative adjuvant treatment.

Fig. 5. Immunohistochemistry of the tumor microenvironment in GBM specimens before and after CART-EGFRvIII infusion. Immunohistochemistry of the tumor.

Suppression of plasma neutrophil elastase–α1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia

Duration of treatment and intervals of radiographic and ctDNA response

Antitumor activity. Antitumor activity. A, maximum change in target lesion size from baseline assessed according to RECIST 1.0 (n = 26). Six patients had.

Fig. 2. Illustrative case. A 22-year-old male patient presented with visual field defects. A: Initial MRI showed pituitary adenoma. B: Suspicious residual.

Presentation transcript:

Fig. 1. Example of proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia in a patient pre-dating the original description in 2007. The patient, a 65 yr old retired schoolteacher, presented with profound recurrent hypomagnesaemia after treatment with a proton pump inhibitor (PPI) for 7 years. It was he who noticed the association and experimented with stopping, starting and switching PPIs. Arrows indicate intravenous magnesium infusions, the hashed bar periods of omeprazole exposure, the crossed bar lansoprazole exposure. Fig. 1. Example of proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia in a patient pre-dating the original description in 2007. The patient, a 65 yr old retired schoolteacher, presented with profound recurrent hypomagnesaemia after treatment with a proton pump inhibitor (PPI) for 7 years. It was he who noticed the association and experimented with stopping . . . Intest Res. 2015 Jul;13(3):227-232. http://dx.doi.org/10.5217/ir.2015.13.3.227